For too long hardworking Americans have been punished at the pharmacy counter while other countries get sweetheart deals behind closed doors, and it’s about time someone put a stop to it. Dr. Mehmet Oz made that plain on Newsmax’s America Right Now when he backed President Trump’s TrumpRx initiative, saying the plan will force a fair playing field so Americans don’t pay more than citizens in other developed nations.
This administration didn’t just talk — on May 12, 2025 President Trump signed an executive order giving drugmakers a 30‑day window to lower prices or face a new pricing regime tied to what other wealthy countries pay. That kind of bold, executive action is what conservatives have been begging for while Washington bureaucrats and lobbyists pretended the problem would fix itself.
The Trump team is also building practical tools, including the forthcoming TrumpRx website that will connect Americans with direct‑to‑consumer pricing and steer government purchases toward the lowest lawful prices, with early deals already struck with major manufacturers. The Pfizer agreement and other negotiated discounts prove the administration’s leverage can deliver real savings, and the site is expected to go live in early 2026 so families can finally see the benefits.
Make no mistake: this isn’t a giveaway — it’s common sense. The Trump administration has secured agreements from big players and even added AstraZeneca to the fold, showing that when the White House stands firm, corporations will negotiate rather than hold ordinary Americans hostage to inflated list prices. That reality shatters the tired narrative that only heavy government control or surrender to Big Pharma are options.
Dr. Oz’s blunt assessment — that Americans have been effectively subsidizing the rest of the world and paying two to four times what peers pay overseas — should outrage every family paying astronomical co‑pays and deductibles. Conservatives know innovation must be preserved, but not at the cost of bankrupting patients; TrumpRx aims to protect both American families and the incentives that produce medical breakthroughs.
Now is the time for patriots to stand behind policies that put Main Street ahead of K Street. Demand transparency, back enforcement of fair pricing, and don’t be fooled by scare tactics from lobbyists who profit while our neighbors choose between medicine and groceries. If Washington won’t stop subsidizing foreign drug markets, then we must elect leaders who will — and TrumpRx is a real step in that fight.
